Living-Donor Liver Transplant Follow-Up: A Single Center Experience

被引:1
|
作者
Laeeq, Syed Mudassir [1 ]
Hanif, Farina M. [1 ]
Luck, Nasir Hassan [1 ]
Mandhwani, Rajesh Kumar [1 ]
Iqbal, Jawed [1 ]
Mehdi, Syed Haider [2 ]
机构
[1] Sindh Inst Urol & Transplantat, Dept Hepatogastroenterol, Karachi 74200, Pakistan
[2] Sindh Inst Urol & Transplantat, Dept Hepatobiliary Surg, Karachi, Pakistan
关键词
Anti-viral agents; Diabetes mellitus; Dyslipidemia; HCV; Hypertension; HEPATITIS-C VIRUS; RISK-FACTORS; HCV; SOFOSBUVIR; INFECTION; RIBAVIRIN;
D O I
10.6002/ect.mesot2016.P122
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Objectives: Liver transplant is a definite treatment of decompensated liver disease. Because of the shortage of livers from deceased donors, living-donor liver transplant is becoming more common. Here, we analyzed our clinical experience in the follow-up care of these patients. Materials and Methods: Liver transplant recipients seen at the Sindh Institute of Urology and Transplantation (Karachi, Pakistan) were included in this analysis. Baseline characteristics and follow-up events were recorded. Results: Our study population included 76 liver transplant patients registered at our clinic. Median age was 42 years, with 62 patients (81.6%) being males. The most common indication of transplant was hepatitis C virus-related cirrhosis (42 patients; 55%), followed by hepatitis B-hepatitis D virus coinfection (8 patients; 10.5%). Anastomotic biliary stricture developed in 16 patients (21.1%), which required biliary stenting. Biliary leak developed in 5 patients (6.6%), and renal cell carcinoma developed in 1 patient. Two recipients died due to hepatitis C virus-related fibrosing cholestasis hepatitis and pulmonary complications. Posttransplant diabetes mellitus developed in 36 (47.1%), hypertension in 17 (38.6%), and dyslipidemia in 19 patients (25%). Of 42 patients with hepatitis C virus infection, 26 were treated with pegylated interferon and ribavirin, of which 65.3% achieved sustained virologic response at 24 weeks. The other 16 patients received sofosbuvir combined with ribavirin for 24 weeks. A sustained virologic response at 12 weeks was achieved in 5 patients, with not yet determined results in the remaining patients. Seven patients were lost to follow-up. Conclusions: Hepatitis C-related cirrhosis was the most common indication for liver transplant, and infection recurrence was observed in our patients. Biliary anastomotic stricture formation was the most prevalent complication after transplant. As liver transplants are becoming more widely available for Pakistani patients at home and abroad, gastroenterologists and trainees in our country should be sensitized, educated, and skilled in the posttransplant care of these patients.
引用
收藏
页码:254 / 257
页数:4
相关论文
共 50 条
  • [1] Infectious complications in living-donor liver transplant recipients: a 9-year single-center experience
    Kim, Y. J.
    Kim, S. I.
    Wie, S. H.
    Kim, Y. R.
    Hur, J. A.
    Choi, J. Y.
    Yoon, S. K.
    Moon, I. S.
    Kim, D. G.
    Lee, M. D.
    Kang, M. W.
    TRANSPLANT INFECTIOUS DISEASE, 2008, 10 (05) : 316 - 324
  • [2] Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years
    Nafady-Hego, Hanaa
    Elgendy, Hamed
    Nafady, Asmaa
    Uemoto, Shinji
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2016, 14 (02) : 207 - 214
  • [3] Post-transplantation lymphoproliferative disorder in living-donor liver transplantation: a single-center experience
    Nakanishi, Chikashi
    Kawagishi, Naoki
    Sekiguchi, Satoshi
    Akamatsu, Yorihiro
    Sato, Kazushige
    Miyagi, Shigehito
    Takeda, Ikuo
    Fukushima, Daizo
    Kobayashi, Yoshinobu
    Ishida, Kazuyuki
    Niizuma, Hidetaka
    Tsuchiya, Shigeru
    Wada, Motoshi
    Nio, Masaki
    Satomi, Susumu
    SURGERY TODAY, 2012, 42 (08) : 741 - 751
  • [4] Outcome of Living-Donor Liver Transplant for Hepatocellular Carcinoma: 15-Year Single-Center Experience in Egypt
    Kamel, Refaat
    Hatata, Yaser
    Hosny, Karim
    Nabil, Ahmed
    Abd-Allah, Alaa El-Deen
    Mostafa, Aaser
    Abdel-Aal, Amr
    Elganzoury, Mahmoud Z.
    Elmalt, Osama
    Marwan, Ibrahim
    Hosny, Adel
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2017, 15 : 12 - 20
  • [5] Acute Rejection Is a Strong Negative Predictor of Graft Survival in Living-Donor Pediatric Renal Transplant: 10-Year Follow-Up in a Single Mexican Center
    Martinez-Mier, Gustavo
    Mendez-Lopez, Marco T.
    Soto-Miranda, Ernesto
    Moreno-Ley, Pedro, I
    Budar-Fernandez, Luis F.
    Rizo-Velazquez, Carlos G.
    Vega-Rojano, Lucia
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2019, 17 (02) : 170 - 176
  • [6] Living-Donor Liver Transplantation in 126 Patients with Biliary Atresia: Single-Center Experience
    Mizuta, K.
    Sanada, Y.
    Wakiya, T.
    Urahashi, T.
    Umehara, M.
    Egami, S.
    Hishikawa, S.
    Okada, N.
    Kawano, Y.
    Saito, T.
    Hayashida, M.
    Takahashi, S.
    Yoshino, H.
    Shimizu, A.
    Takatsuka, Y.
    Kitamura, T.
    Kita, Y.
    Uno, T.
    Yoshida, Y.
    Hyodo, M.
    Sakuma, Y.
    Fujiwara, T.
    Ushijima, K.
    Sugimoto, K.
    Ohmori, M.
    Ohtomo, S.
    Sakamoto, K.
    Nakata, M.
    Yano, T.
    Yamamoto, H.
    Kobayashi, E.
    Yasuda, Y.
    Kawarasaki, H.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (10) : 4127 - 4131
  • [7] HLA Tissue Typing Has No Effect on the Outcome of Patients Undergoing a Living-donor Liver Transplant: A Single-center Experience in Egypt
    Yosry, Ayman
    Said, Mohamed
    Esmat, Gamal
    Al-Serafy, Magdy
    Omar, Ashraf
    Doss, Wahid
    Omran, Dalia
    Saad, Yasmin
    Kamel, Sanna
    Abdel-Bary, Akram
    Hatata, Yaser
    Hosny, Adel
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2012, 10 (02) : 136 - 140
  • [8] New-onset diabetes mellitus developing in Asian adult living donor liver transplant recipients: a single-center experience
    Harada, Nobuhiro
    Sugawara, Yasuhiko
    Akamatsu, Nobuhisa
    Kaneko, Junichi
    Tamura, Sumihito
    Aoki, Taku
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Yamashiki, Noriyo
    Kokudo, Norihiro
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2013, 20 (06) : 634 - 638
  • [9] Single-Center Experience of Consecutive 522 Cases of Hepatic Artery Anastomosis in Living-Donor Liver Transplantation
    Song, S.
    Kwon, C. H. D.
    Moon, H. H.
    Lee, S.
    Kim, J. M.
    Joh, J. -W.
    Lee, S. -K.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (06) : 1905 - 1911
  • [10] Predictive Factors of De Novo Malignancies After Living-Donor Liver Transplantation: A Single-Center Experience
    Wahab, Mohamed Abdel
    Abdel-Khalek, Ehab E.
    Elshoubary, Mohamed
    Yassen, Amr Mohamed
    Salah, Tarek
    Sultan, Ahmed Mohamed
    Fathy, Omar
    Elmorshedi, Mohamed
    Shiha, Usama
    Elsadany, Mohamed
    Adly, Reham
    Samy, Mohamed
    Shehta, Ahmed
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (02) : 636 - 644